Nonrandom structural and numerical chromosome changes in non‐small‐cell lung cancer

Cytogenetic studies were performed on 27 tumor cell lines (most of which were derived from metastatic lesions) and four fresh malignant pleural and pericardia! effusions from 30 patients with non‐small‐cell lung cancer (non‐SCLC). Many clonal structural (deletions and nonreciprocal translations) and numerical abnormalities were found in each specimen. Statistical analysis revealed these changes were nonrandomly distributed among the chromosomes. A statistically significant number of chromosomal breakpoints were seen in regions 1 q 1, 1 q3, 3p1, 3p2, 3q1, 3q2, 7q1, 13p1, 14p1, 15p1, and 17q1 when the regions were compared to the total haploid complement. In addition, when a given region was compared to other regions within the same chromosome, statistically significant numbers of breakpoints were noted for regions 1q3, 5q1, 7q1, 13p1, 14p1, 15p1, 16q2, 17q1, and 21p1. Specific chromosome bands showing the most frequent involvement in structural abnormalities were (in descending order) 3p 14.2, 3q21, 19q13, 11p15, 1q11, 7q111, 1q21, 3p23, and 3p21. The breakpoints indicate areas to look for new dominant oncogenes activated by translocations, while the areas of deletions and loss of material by nonreciprocal translocations highlight areas to search for recessive oncogenes. These cytogenetic studies represent strong evidence that multiple genetic lesions are associated with the development of metastatic lung cancer, and provide a roadmap to search for new genes involved in the pathogenesis of lung cancer.

[1]  L. Irving,et al.  Cytogenetics of non‐small cell lung cancer: Analysis of consistent non‐random abnormalities , 1990, Genes, chromosomes & cancer.

[2]  R. Vollmer,et al.  Loss of heterozygosity for genes on 11p and the clinical course of patients with lung carcinoma. , 1990, Cancer research.

[3]  R. Weinberg,et al.  Frequent inactivation of the retinoblastoma anti-oncogene is restricted to a subset of human tumor cells. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[4]  A. Harris,et al.  Increased expression of mutant forms of p53 oncogene in primary lung cancer , 1990, The Lancet.

[5]  A. Poustka,et al.  Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping , 1990, Nature.

[6]  D. Housman,et al.  Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus , 1990, Cell.

[7]  J. Minna,et al.  Molecular mapping of deletion sites in the short arm of chromosome 3 in human lung cancer , 1990, Genes, chromosomes & cancer.

[8]  H. Olsson,et al.  No abnormal C-band polymorphism in lung cancer patients. , 2008, Hereditas.

[9]  F. Collins,et al.  Mutations in the p53 gene occur in diverse human tumour types , 1989, Nature.

[10]  J. Testa,et al.  Recurring loss involving chromosomes 1, 3, and 22 in malignant mesothelioma: Possible sites of tumor suppressor genes , 1989, Genes, chromosomes & cancer.

[11]  J. Minna,et al.  p53: a frequent target for genetic abnormalities in lung cancer. , 1989, Science.

[12]  M. Oshimura,et al.  Concordant deletions of chromosome 3p and loss of heterozygosity for chromosomes 13 and 17 in small cell lung carcinoma. , 1989, Cancer research.

[13]  D. Albertson,et al.  Frequency and extent of allelic loss in the short arm of chromosome 3 in nonsmall‐cell lung cancer , 1989, Genes, chromosomes & cancer.

[14]  J. L. Bos,et al.  ras oncogenes in human cancer: a review. , 1989, Cancer research.

[15]  S. Naylor,et al.  Retention of chromosome 3 in extrapulmonary small cell cancer shown by molecular and cytogenetic studies. , 1989, Journal of the National Cancer Institute.

[16]  J. Willey,et al.  Differential DNA sequence deletions from chromosomes 3, 11, 13, and 17 in squamous-cell carcinoma, large-cell carcinoma, and adenocarcinoma of the human lung. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[17]  I. Ramzy,et al.  Cytogenetic abnormalities common to adenocarcinoma metastatic to the pleura. , 1989, Cancer genetics and cytogenetics.

[18]  R. Ueda,et al.  Expression and amplification of myc gene family in small cell lung cancer and its relation to biological characteristics. , 1989, Cancer research.

[19]  S. Naylor,et al.  The DNF15S2 locus at 3p21 is transcribed in normal lung and small cell lung cancer. , 1989, Genomics.

[20]  J. Rey,et al.  Involvement of chromosomes 1, 3, and i(8q) in lung adenocarcinoma. , 1989, Cancer genetics and cytogenetics.

[21]  D. Becker,et al.  Loss of heterozygosity at chromosomal regions 3p and 13q in non-small-cell carcinoma of the lung represents low-frequency events. , 1989, Genomics.

[22]  R. Makuch,et al.  myc family DNA amplification in small cell lung cancer patients' tumors and corresponding cell lines. , 1988, Cancer research.

[23]  J. Battey,et al.  Multiple mechanisms for transcriptional regulation of the myc gene family in small-cell lung cancer , 1988, Molecular and cellular biology.

[24]  J. Minna,et al.  Restriction fragment length polymorphism studies show consistent loss of chromosome 3p alleles in small cell lung cancer patients' tumors. , 1988, The Journal of clinical investigation.

[25]  J. Minna,et al.  Abnormalities in structure and expression of the human retinoblastoma gene in SCLC. , 1988, Science.

[26]  F. Mitelman,et al.  Isochromosomes i(8q) or i(9q) in three adenocarcinomas of the lung. , 1988, Cancer genetics and cytogenetics.

[27]  J. Haines,et al.  Von Hippel–Lindau disease maps to the region of chromosome 3 associated with renal cell carcinoma , 1988, Nature.

[28]  N. Bleehen,et al.  Cytogenetic abnormalities in human small cell lung carcinoma: cell lines characterized for myc gene amplification. , 1988, Cancer genetics and cytogenetics.

[29]  J. Yokota,et al.  Altered expression of the retinoblastoma (RB) gene in small-cell carcinoma of the lung. , 1988, Oncogene.

[30]  J. Osinga,et al.  Deletion of a DNA sequence at the chromosomal region 3p21 in all major types of lung cancer , 1987, Nature.

[31]  M. Noguchi,et al.  Loss of genes on the short arm of chromosome 11 in human lung carcinomas. , 1987, Japanese journal of cancer research : Gann.

[32]  M Terada,et al.  Loss of heterozygosity on chromosomes 3, 13, and 17 in small-cell carcinoma and on chromosome 3 in adenocarcinoma of the lung. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[33]  S. Pathak,et al.  Involvement of chromosome 7 in primary lung tumor and nonmalignant normal lung tissue. , 1987, Cancer research.

[34]  J. Minna,et al.  Molecular analysis of the short arm of chromosome 3 in small-cell and non-small-cell carcinoma of the lung. , 1987, The New England journal of medicine.

[35]  U. Novak,et al.  Heterogeneous cytogenetic abnormalities in small cell lung cancer cell lines. , 1987, Cancer research.

[36]  Y. Fan,et al.  Cytogenetic studies of four human lung adenocarcinoma cell lines. , 1987, Cancer Genetics and Cytogenetics.

[37]  R. Makuch,et al.  myc family oncogene amplification in tumor cell lines established from small cell lung cancer patients and its relationship to clinical status and course. , 1987, The Journal of clinical investigation.

[38]  J. Rey,et al.  Deletion 3p in two lung adenocarcinomas metastatic to the brain. , 1987, Cancer genetics and cytogenetics.

[39]  J. Minna,et al.  Loss of heterozygosity of chromosome 3p markers in small-cell lung cancer , 1987, Nature.

[40]  S. Jhanwar,et al.  Cytogenetic and histologic correlations in malignant lymphoma. , 1987, Blood.

[41]  R. Kurzrock,et al.  Trisomy 12 correlates with elevated expression of p21 ras in a human adenosquamous carcinoma of the lung. , 1986, Cancer genetics and cytogenetics.

[42]  R. Kurzrock,et al.  Differential expression of p21ras gene products among histological subtypes of fresh primary human lung tumors. , 1986, Cancer research.

[43]  R. Stahel,et al.  Chromosome changes in malignant mesothelioma. , 1986, Cancer genetics and cytogenetics.

[44]  J. Battey,et al.  Human small-cell lung cancers show amplification and expression of the N-myc gene. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[45]  J. Minna,et al.  Growth of cell lines and clinical specimens of human non-small cell lung cancer in a serum-free defined medium. , 1986, Cancer research.

[46]  J. Battey,et al.  Molecular genetic analysis reveals chromosomal deletion, gene amplification, and autocrine growth factor production in the pathogenesis of human lung cancer. , 1986, Cold Spring Harbor symposia on quantitative biology.

[47]  A. Gazdar,et al.  Cell culture methods for human lung cancer. , 1986, Cancer genetics and cytogenetics.

[48]  J. Battey,et al.  L-myc, a new myc-related gene amplified and expressed in human small cell lung cancer , 1985, Nature.

[49]  C. Harris,et al.  Asbestos-associated chromosomal changes in human mesothelial cells. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[50]  J. Bergh,et al.  Amplification of the c-myc oncogene in a subpopulation of human small cell lung cancer. , 1985, Cancer research.

[51]  J. Bergh,et al.  Karyotypic characterization of established cell lines and short-term cultures of human lung cancers. , 1985, Cancer genetics and cytogenetics.

[52]  J. Teyssier,et al.  Trisomy 7 in a lung carcinoid tumor: precocious index of malignant transformation? , 1985, Cancer genetics and cytogenetics.

[53]  J. Whang‐Peng,et al.  Cytogenetics of human small cell lung cancer. , 1985, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[54]  J. Minna,et al.  Amplification and expression of the c-myc oncogene in human lung cancer cell lines , 1983, Nature.

[55]  S. Jhanwar,et al.  Characterization of two newly established human cell lines from patients with large‐cell anaplastic lung carcinoma , 1982, Cancer.

[56]  A. Tsiatis,et al.  Statistical analysis of cytogenetic abnormalities in human cancer cells. , 1982, Cancer genetics and cytogenetics.

[57]  J. Minna,et al.  A nonrandom chromosomal abnormality, del 3p(14-23), in human small cell lung cancer (SCLC). , 1982, Cancer genetics and cytogenetics.

[58]  J. Minna,et al.  Specific chromosome defect associated with human small-cell lung cancer; deletion 3p(14-23). , 1982, Science.

[59]  Y. Shimosato,et al.  Histological Typing of Lung Tumours 1 , 1981 .

[60]  N. Wake,et al.  Chromosomes and causation of human cancer and leukemia. XLIV. A method for chromosome analysis of solid tumors. , 1981, Cancer genetics and cytogenetics.

[61]  Iscn.  International System for Human Cytogenetic Nomenclature , 1978 .

[62]  M. Oshimura,et al.  Chromosomes and causation of human cancer and leukemia. XX. Banding patterns of primary tumors. , 1977, Journal of the National Cancer Institute.

[63]  V. Pickthall.  Detailed cytogenetic study of a metastatic bronchial carcinoma. , 1976, British Journal of Cancer.

[64]  N. Ayraud.  [Identification by means of heat denaturation of chromosome aberrations in 6 human metastatic tumors]. , 1975, Biomedicine / [publiee pour l'A.A.I.C.I.G.].

[65]  M. Oshimura,et al.  Chromosomes and causation of human cancer and leukemia. X Banding patterns in cancerous effusions , 1975, Cancer.

[66]  J. Tjio,et al.  Chromosome preparations of bone marrow cells without prior in vitro culture or in vivo colchicine administration. , 1962, Stain technology.

[67]  J A TAIANA,et al.  [Cancer of the lung]. , 1952, The Journal of the International College of Surgeons.